Clinical Trial Update: Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 trial update for ASTX727 in lower-risk myelodysplastic syndromes indicates the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• ASTX727 (cedazuridine/decitabine)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Lower-risk Myelodysplastic | Phase 1 | Status: ACTIVE_NOT_RECRUITING